Dopamine β-hydroxylase (DβH), an essential component in the catecholamine biosynthesis pathway, which catalyzes the hydroxylation of dopamine to produce noradrenaline in the SNS, is a candidate for the management of HTN as well as other sympathetically activated cardiovascular diseases, including HF [145]. The gene discussed is DBH; the disease is hypertensive disorder.